177 related articles for article (PubMed ID: 28718365)
21. A 9‑lncRNA risk score system for predicting the prognosis of patients with hepatitis B virus‑positive hepatocellular carcinoma.
Liu H; Zhao P; Jin X; Zhao Y; Chen Y; Yan T; Wang J; Wu L; Sun Y
Mol Med Rep; 2019 Jul; 20(1):573-583. PubMed ID: 31115573
[TBL] [Abstract][Full Text] [Related]
22. A prognostic 4-gene expression signature for squamous cell lung carcinoma.
Li J; Wang J; Chen Y; Yang L; Chen S
J Cell Physiol; 2017 Dec; 232(12):3702-3713. PubMed ID: 28160492
[TBL] [Abstract][Full Text] [Related]
23. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
[TBL] [Abstract][Full Text] [Related]
24. Prognostic implications of aberrantly expressed methylation‑driven genes in hepatocellular carcinoma: A study based on The Cancer Genome Atlas.
Li J; Chen N; Gong X
Mol Med Rep; 2019 Dec; 20(6):5304-5314. PubMed ID: 31661127
[TBL] [Abstract][Full Text] [Related]
25. A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.
Zhang J; Chong CC; Chen GG; Lai PB
PLoS One; 2015; 10(6):e0128628. PubMed ID: 26046780
[TBL] [Abstract][Full Text] [Related]
26. Association of long noncoding RNA and c-JUN expression in hepatocellular carcinoma.
El-Tawdi AH; Matboli M; El-Nakeep S; Azazy AE; Abdel-Rahman O
Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):869-77. PubMed ID: 27215316
[TBL] [Abstract][Full Text] [Related]
27. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
28. High serum microRNA-122 level is independently associated with higher overall survival rate in hepatocellular carcinoma patients.
Xu Y; Bu X; Dai C; Shang C
Tumour Biol; 2015 Jun; 36(6):4773-6. PubMed ID: 25636448
[TBL] [Abstract][Full Text] [Related]
29. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma.
Yan TH; Yang H; Jiang JH; Lu SW; Peng CX; Que HX; Lu WL; Mao JF
Int J Clin Exp Pathol; 2015; 8(4):4126-31. PubMed ID: 26097602
[TBL] [Abstract][Full Text] [Related]
31. ALDH1A1-overexpressing cells are differentiated cells but not cancer stem or progenitor cells in human hepatocellular carcinoma.
Tanaka K; Tomita H; Hisamatsu K; Nakashima T; Hatano Y; Sasaki Y; Osada S; Tanaka T; Miyazaki T; Yoshida K; Hara A
Oncotarget; 2015 Sep; 6(28):24722-32. PubMed ID: 26160842
[TBL] [Abstract][Full Text] [Related]
32. Development of an oncogenic dedifferentiation SOX signature with prognostic significance in hepatocellular carcinoma.
Li MM; Tang YQ; Gong YF; Cheng W; Li HL; Kong FE; Zhu WJ; Liu SS; Huang L; Guan XY; Ma NF; Liu M
BMC Cancer; 2019 Aug; 19(1):851. PubMed ID: 31462277
[TBL] [Abstract][Full Text] [Related]
33. Decreased levels of miR-34a and miR-217 act as predictor biomarkers of aggressive progression and poor prognosis in hepatocellular carcinoma.
Tian YW; Shen Q; Jiang QF; Wang YX; Li K; Xue HZ
Minerva Med; 2017 Apr; 108(2):108-113. PubMed ID: 27879964
[TBL] [Abstract][Full Text] [Related]
34. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues.
Ajdarkosh H; Dadpay M; Yahaghi E; Pirzaman ER; Fayyaz AF; Darian EK; Mokarizadeh A
Diagn Pathol; 2015 Aug; 10():135. PubMed ID: 26248880
[TBL] [Abstract][Full Text] [Related]
35. Expression and prognostic significance of the alpha B-crystallin gene in human hepatocellular carcinoma.
Tang Q; Liu YF; Zhu XJ; Li YH; Zhu J; Zhang JP; Feng ZQ; Guan XH
Hum Pathol; 2009 Mar; 40(3):300-5. PubMed ID: 18992912
[TBL] [Abstract][Full Text] [Related]
36. Role of the hypoxia-related gene, JMJD1A, in hepatocellular carcinoma: clinical impact on recurrence after hepatic resection.
Yamada D; Kobayashi S; Yamamoto H; Tomimaru Y; Noda T; Uemura M; Wada H; Marubashi S; Eguchi H; Tanemura M; Doki Y; Mori M; Nagano H
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S355-64. PubMed ID: 21607773
[TBL] [Abstract][Full Text] [Related]
37. Oncogenic function and prognostic significance of Abelson interactor 1 in hepatocellular carcinoma.
Wang JL; Yan TT; Long C; Cai WW
Int J Oncol; 2017 May; 50(5):1889-1898. PubMed ID: 28339046
[TBL] [Abstract][Full Text] [Related]
38. Clinical potential of miRNA-221 as a novel prognostic biomarker for hepatocellular carcinoma.
Chen F; Li XF; Fu DS; Huang JG; Yang SE
Cancer Biomark; 2017; 18(2):209-214. PubMed ID: 27983537
[TBL] [Abstract][Full Text] [Related]
39. Integrated analysis of prognostic gene expression profiles from hepatitis B virus-positive hepatocellular carcinoma and adjacent liver tissue.
Kim BY; Suh KS; Lee JG; Woo SR; Park IC; Park SH; Han CJ; Kim SB; Jeong SH; Yeom YI; Yang SJ; Kim CM; Cho SJ; Yoo YD; Cho MH; Jang JJ; Choi DW; Lee KH
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S328-38. PubMed ID: 21533656
[TBL] [Abstract][Full Text] [Related]
40. Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.
Ruan DY; Lin ZX; Li Y; Jiang N; Li X; Wu DH; Wang TT; Chen J; Lin Q; Wu XY
World J Gastroenterol; 2015 May; 21(18):5598-606. PubMed ID: 25987785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]